2-Methoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98+%, 1g

2,9-Diaminoanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone, 98%, 250mg

2-Nitroterephthalic acid, 95.0%, 100g

4-(4-Ethylpiperazin-1-ylmethyl)benzoic acid, 95.0%, 5g

2-Methylindoline>98.0%(GC)25mL

Ethyl 2-bromo-1,4-dimethyl-1H-imidazole-5-carboxylate, 98%, 100mg

4-(Piperidin-1-yl)butan-1-ol, 95.0%, 5g

2-[(Diphenylphosphoryl)methyl]phenol>98.0%(HPLC)5g

GC-Kapillarsäule ROTI®Cap-FFAP, polar, L 30 m, Ø-Innen 0,25 mm, Filmd. 0,25 µm, 1 Stück

5-Amino-2-bromo-4-chlorobenzonitrile, 95.0%, 5g

(2S,4S)-1-((S)-2-((tert-Butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylic acid, 98%, 250mg

[2-(isopropylthio)phenyl]amine hydrochloride, 95.0%, 500g

5,5-Dimethyl-1-pyrroline-n-oxide, 95.0%, 25g